Results 141 to 150 of about 14,827 (208)

Screening of FDA-Approved Small Molecules to Discover Inhibitors of the <i>Pseudomonas aeruginosa</i> Quorum-Sensing Enzyme, PqsE. [PDF]

Biochemistry
Jones HA, Baxter MJ, Zimmermann N, Li A, Perrault Uptmor KA, Taylor IR.   +5 more
europepmc   +1 more source

Real-world implementation of continuous subcutaneous foslevodopa/foscarbidopa in advanced Parkinson's disease: first clinical experience from the Middle East. [PDF]

Ther Adv Neurol Disord
Mittal SO, Waqar K, De Freitas E, Abdelmajid Y, Anjum A, Brown L, Thomas M.   +6 more
europepmc   +1 more source

Iatrogenic hemoperitoneum and sigmoid colon injury from malpositioned apomorphine infusion device in advanced Parkinson's disease. [PDF]

Radiol Case Rep
Hughes C, Fazio T, Umstad C.
europepmc   +1 more source

Continuous subcutaneous levodopa and foslevodopa infusion therapy for motor symptoms of Parkinson disease: A systematic review of observational studies. [PDF]

Medicine (Baltimore)
Ali A, Cheema WA, Shamoon M, Azam H, Yousuf D, Tanveer A, Asif W, Nisar F, Ghafoor LA, Talha M, Ali MA, Saleem U, Shabbir MA, Abdullah A, Sharma M.   +14 more
europepmc   +1 more source

Clinical Studies Using Intranasal Therapies for Parkinson's Disease: A Review. [PDF]

Adv Pharm Bull
Vahidi R, Bukanian M, Kachooeian M.
europepmc   +1 more source

Real-world experience with foslevodopa/foscarbidopa in Germany: therapeutic insights and lessons learned. [PDF]

Neurol Res Pract
Weise D, Warnecke T, Buhmann C, Ebersbach G, Eggers C, Falkenburger B, Höglinger G, Mollenhauer B, Pedrosa D, Südmeyer M, Weiss D, Kassubek J, Jost WH.   +12 more
europepmc   +1 more source

Theiler's murine encephalomyelitis virus as the infectious agent for a virally induced mouse model of Parkinson's disease. [PDF]

Brain Behav Immun Health
Kang TW, Srinivasan R, Brinkmeyer-Langford C, Welsh CJ.   +3 more
europepmc   +1 more source

Apomorphine differentially engages the cAMP and β-arrestin signaling pathways relative to dopamine at human dopamine receptors. [PDF]

J Neural Transm (Vienna)
Yegla B, Rubin J, Grall M, Formella A, Jenner P.   +4 more
europepmc   +1 more source

The effects of war on patients with Parkinson's disease. [PDF]

Clin Park Relat Disord
Salari M, Etemadifar M, Rezaei K, Hojjatipour F.   +3 more
europepmc   +1 more source

Characterization of [³H]MCL-524, a Potent Dopamine D₂ ^high Receptor Agonist. [PDF]

ACS Omega
Subburaju S, Sromek AW, Seeman P, Neumeyer JL.   +3 more
europepmc   +1 more source